MYGN Myriad Genetics Inc

Myriad Genetics Inc is a molecular diagnostic company. It develops and markets novel predictive medicine, personalized medicine and prognostic medicine tests. It also provides physicians with information to solve unmet medical needs.

$18.95  +0.05 (0.27%)
As of 06/24/2022 15:59:59 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  02/26/2001
Outstanding shares:  80,343,165
Average volume:  604,450
Market cap:   $1,518,485,819
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      2614153
Valuation   (See tab for details)
PE ratio:   -185.67
PB ratio:   1.60
PS ratio:   2.23
Return on equity:   -0.86%
Net income %:   -1.20%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy